Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Nicole Fawcett photo
Breast cancer graphics
Health Lab
How Hereditary Genetic Testing Results Impact Breast Cancer Treatment
Breast cancer patients who test positive for an inherited genetic mutation, such as having the BRCA1 or BRCA2 gene, may be receiving treatment based on future cancer risk, rather than guideline approved treatments for their diagnosed cancers, study finds.
Breast cancer scan image
Health Lab
Annual Over Biennial Mammograms Linked to Less Advanced Breast Cancer
Mammograms, an essential part of breast cancer screening, could increase overall health outcomes if performed annually according to a new study.
Conversation boxes on a yellow background
Health Lab
U-M Tackles #MedToo with Large-Scale Study on Sexual Harassment
A survey of Medical School faculty describes the impact of sexual harassment on physicians, helping leaders to outline paths to promote a culture of civility and respect.
Reshma Jagsi
Health Lab
To Diversify Leadership, Academic Medicine Should Implement Term Limits
To diversify leadership, researchers say term limits may create more opportunities for women and minorities in academic medicine.
Doctor looking at computer screen
Health Lab
Study: Aggressive Breast Cancers Store Large Amounts of Energy, Which Enables It to Spread
The finding suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.
Image of laptop with medical records
Health Lab
Patients Say Ask Before Using Medical Records for Research
A new study finds patients want to provide consent before researchers or hospitals use their medical records for research.
News Release
Grades are in: Gender equality report card reveals systematic underrepresentation of women in STEM
An institutional report card for gender equity representing more than 500 institutions worldwide reveals that women are not equally promoted, recruited or retained to senior roles, and that policies to support women in science are lacking.
Dr. Meredith Morgan, Dr. Kyle Cuneo, and Dr. Ted Lawrence
Health Lab
New Drug Shows Encouraging Survival Results for Pancreatic Cancer
An early clinical trial on pancreatic cancer research finds a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.
Health Lab
Who’s Minding the Children? Female Physicians Report Skipping Scientific Conferences Because of Child Care
A survey of early career oncologists suggests onsite child care could open scientific meetings to more women attendees.
Doctors looking at sample
Health Lab
Newly Defined Cancer Driver is Fast, Furious and Loud
Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.
Doctors looking at screen
Health Lab
New Way to Predict Complications After Larynx Cancer Surgery
When the surgical wound doesn’t heal right, it can send some patients back to the operating room. A new technique tested at U-M could help identify which patients are at highest risk.
Health Lab
What Did My Doctor Say? What to Do When You Don’t Understand
A Rogel Cancer Center doctor offers tips to help patients leave their oncology appointments understanding their treatment.
Health Lab
Researchers Find New Target to Improve Response to Cancer Immunotherapy
A U-M study is the first to define how a little-known type of cell death impacts tumor cells and immune cells.
Vaccine shot
Health Lab
Study: Therapy Completely Clears HPV in One-Third of Cervical Precancers
Clinical trial shows promise of immune treatment against HPV infections that lead to cancer
Doctors looking at screen
Health Lab
A Protein’s Surprising Role Offers Clues to Limit Graft-vs.-Host Disease
While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.
  • 4
  • 5
  • 6